107 related articles for article (PubMed ID: 7517404)
1. Laminin SIKVAV peptide-induced angiogenesis in vivo is potentiated by neutrophils.
Kibbey MC; Corcoran ML; Wahl LM; Kleinman HK
J Cell Physiol; 1994 Jul; 160(1):185-93. PubMed ID: 7517404
[TBL] [Abstract][Full Text] [Related]
2. Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo.
Grant DS; Kinsella JL; Fridman R; Auerbach R; Piasecki BA; Yamada Y; Zain M; Kleinman HK
J Cell Physiol; 1992 Dec; 153(3):614-25. PubMed ID: 1280280
[TBL] [Abstract][Full Text] [Related]
3. Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model.
Kibbey MC; Grant DS; Kleinman HK
J Natl Cancer Inst; 1992 Nov; 84(21):1633-8. PubMed ID: 1279183
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated wild-type p53 overexpression inhibits endothelial cell differentiation in vitro and angiogenesis in vivo.
Riccioni T; Cirielli C; Wang X; Passaniti A; Capogrossi MC
Gene Ther; 1998 Jun; 5(6):747-54. PubMed ID: 9747454
[TBL] [Abstract][Full Text] [Related]
5. Matrigel cytometry: a novel method for quantifying angiogenesis in vivo.
Adini A; Fainaru O; Udagawa T; Connor KM; Folkman J; D'Amato RJ
J Immunol Methods; 2009 Mar; 342(1-2):78-81. PubMed ID: 19109967
[TBL] [Abstract][Full Text] [Related]
6. Melanoma cells selected for adhesion to laminin peptides have different malignant properties.
Yamamura K; Kibbey MC; Kleinman HK
Cancer Res; 1993 Jan; 53(2):423-8. PubMed ID: 8417834
[TBL] [Abstract][Full Text] [Related]
7. In vitro effects of SIKVAV retro and retro-enantio analogues on tumor metastatic events.
Almiñana N; Grau-Oliete MR; Reig F; Rivera-Fillat MP
Peptides; 2004 Feb; 25(2):251-9. PubMed ID: 15063006
[TBL] [Abstract][Full Text] [Related]
8. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor.
Passaniti A; Taylor RM; Pili R; Guo Y; Long PV; Haney JA; Pauly RR; Grant DS; Martin GR
Lab Invest; 1992 Oct; 67(4):519-28. PubMed ID: 1279270
[TBL] [Abstract][Full Text] [Related]
9. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
Héroult M; Bernard-Pierrot I; Delbé J; Hamma-Kourbali Y; Katsoris P; Barritault D; Papadimitriou E; Plouet J; Courty J
Oncogene; 2004 Mar; 23(9):1745-53. PubMed ID: 15001987
[TBL] [Abstract][Full Text] [Related]
10. The laminin alpha 1 chain Ile-Lys-Val-Ala-Val (IKVAV)-containing peptide promotes liver colonization by human colon cancer cells.
Bresalier RS; Schwartz B; Kim YS; Duh QY; Kleinman HK; Sullam PM
Cancer Res; 1995 Jun; 55(11):2476-80. PubMed ID: 7758002
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of endothelial cell differentiation on a glycosylated reconstituted basement membrane complex.
Kuzuya M; Satake S; Miura H; Hayashi T; Iguchi A
Exp Cell Res; 1996 Aug; 226(2):336-45. PubMed ID: 8806437
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis and radiation response modulation after vascular endothelial growth factor receptor-2 (VEGFR2) blockade.
Li J; Huang S; Armstrong EA; Fowler JF; Harari PM
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1477-85. PubMed ID: 16029810
[TBL] [Abstract][Full Text] [Related]
13. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells.
Iwasaka C; Tanaka K; Abe M; Sato Y
J Cell Physiol; 1996 Dec; 169(3):522-31. PubMed ID: 8952701
[TBL] [Abstract][Full Text] [Related]
14. Murine epidermal growth factor (EGF) fragment (33-42) inhibits both EGF- and laminin-dependent endothelial cell motility and angiogenesis.
Nelson J; Allen WE; Scott WN; Bailie JR; Walker B; McFerran NV; Wilson DJ
Cancer Res; 1995 Sep; 55(17):3772-6. PubMed ID: 7543818
[TBL] [Abstract][Full Text] [Related]
15. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy.
Benelli R; Adatia R; Ensoli B; Stetler-Stevenson WG; Santi L; Albini A
Oncol Res; 1994; 6(6):251-7. PubMed ID: 7532474
[TBL] [Abstract][Full Text] [Related]
17. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid.
Masso-Welch PA; Zangani D; Ip C; Vaughan MM; Shoemaker S; Ramirez RA; Ip MM
Cancer Res; 2002 Aug; 62(15):4383-9. PubMed ID: 12154044
[TBL] [Abstract][Full Text] [Related]
19. The role of laminin-1 in the modulation of radiation damage in endothelial cells and differentiation.
Rose RW; Grant DS; O'Hara MD; Williamson SK
Radiat Res; 1999 Jul; 152(1):14-28. PubMed ID: 10381837
[TBL] [Abstract][Full Text] [Related]
20. Angiostatin inhibits extracellular HIV-Tat-induced inflammatory angiogenesis.
Benelli R; Morini M; Brigati C; Noonan DM; Albini A
Int J Oncol; 2003 Jan; 22(1):87-91. PubMed ID: 12469189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
